Investor ideas AI technology ideas
Point Roberts, WA and Vancouver, BC – May 24, 2021 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a global source of information for investors covering artificial intelligence (AI) presents today’s edition of The AI Eye – watch stock market news, trade tracking and artificial intelligence advancements.
Listen to today’s podcast:
AI Eye Episode 560: Shares Discussed: (NYSE: $ YEXT) (NasdaqGS: $ KRBP)
SHARE THE PODCAST:
Hear the Eye of AI on Spotify
Today’s column – The AI Eye – Watch Stock News, Trade Tracking, and Artificial Intelligence Advances
Shares discussed: (NYSE: YEXT) (NasdaqGS: KRBP)
AI research firm Yext, Inc. (NYSE: YEXT) announced the launch of Support Answers, “a suite of enterprise research solutions designed for customer support teams.” This will use modern artificial intelligence-based solutions to provide answers to “FAQs, product manuals, help articles, etc.” from a company”. Marc Ferrentino, Chief Strategy Officer at Yext, said:
“Customers have always expressed their aversion to contacting customer support, but for a very long time companies have not had the technology powerful enough to independently solve their problems. Today that is changing with the launch of Support Answers, which harnesses the multiples of search algorithms to interpret people’s intent and provide direct and contextually relevant answers in a way that meets the needs and expectations of consumers, and saves the business time and money. “
Kiromic BioPharma, Inc. (NasdaqGS: KRBP) has submitted a new investigational drug (IND) to the United States Food and Drug Administration (FDA) for a Phase 1 clinical trial, derived from the neural network platform d Company’s proprietary artificial intelligence (Diamond AI), which “has the potential to be a universal CAR T-Cell therapy for any solid malignancy that expresses the biomarker Iso-mesothelin, with higher efficiency, higher safety, as well as lower manufacturing and distribution costs. ” Maurizio Chiriva-Internati, CEO of Kiromic, explained:
Kiromic occupies a unique position as its bioinformatics engine combines CancerDiff, a data mining tool for identifying preferred tumor isoforms, with Diamond, an AI-driven immunogenic peptide identification system.
This combination allows Kiromic to identify targetable sections of a tumor isoform (peptides) that are a unique signature of cancer cells.
The advantage of the Kiromic system is twofold: 1) it saves time and money by prioritizing selective tumor targets, and 2) it maximizes the probability of identifying safe targets by increasing the specificity of targeting.
Commercial use of AI valued at $ 1.8 T by 2027
A report published by Research and Markets analyzing the global general artificial intelligence market, finds that “the potential for productivity gains for the commercial use of AI is approximately $ 1.8 T in economic value by 2027 “. Another excerpt from the report description states that this:
“… will be nine times more with the use of the general purpose AI solutions market compared to the current silo AI approach. Productivity gains will be realized through transactions carried out by autonomous agents. or “bots.” It is estimated that more than 8% of global economic activity in 2027 will be carried out autonomously by some sort of AI solution, while this represents less than one percent today. This represents a dramatic increase in the use of AI for business, industry and government automation. “
The report also predicts that AI integrated in building infrastructure and equipment will reach $ 18.1 globally by 2026, the general-purpose AI market will reach $ 4.25 billion globally. ” By 2026 for enterprise applications and solutions, the global market for general purpose AI support for big data and prescriptive analytics will reach $ 1.35 billion, and that more than 35% of business value will be directly or indirectly attributable to general purpose AI solutions by 2027.
Sam Mowers, Investorideas.com
Read and listen to other editions of the AI Eye
For a list of artificial intelligence stocks on Investorideas.com, visit here or become a member of Investor Ideas
Investors can trade these stocks and other ideas on our site using our list of the best stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com – News that inspires great investing ideas
Investorideas.com publishes breaking news, third party stock research, guest articles and original articles and podcasts in major stock market sectors. Find out how to invest in stocks and get ideas from investors in Cannabis, Crypto, AI & IoT, Mining, Sports Biotech, Water, Renewable Energy, Gaming and more . Investor Idea’s original branded content includes podcasts and columns: Crypto Corner, Play by Play sports and stock market news, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast, Cleantech and Climate Change, Exploring Mining, Betting on Gaming Podcast Stocks and AI Eye Podcast.
Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most available audio platforms.
Visit the Podcast page on Investorideas.com:
The AI eye – Watching stock market news, trade tracking and advancements in artificial intelligence is an original content brand of Investorideas.com
Follow us on twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our mobile app for iPhone and Android
800 665 0411